CervoMed Inc. Common Stock (CRVO)
PHARMACEUTICAL PREPARATIONS
CervoMed Inc. Common Stock (CRVO) is listed on Nasdaq, where it has traded since June 18, 1996.
- Listed On
- Nasdaq
- Listed Since
- June 18, 1996
- Employees
- 15
- Market Cap
- $38M
About CervoMed Inc. Common Stock
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 34 institutions reported holding CRVO, with 1.7 million shares worth $5.4 million in aggregate. The largest reported holder was Woodline Partners, with 688,987 shares worth $2.1 million. Of the 5 largest holders listed below, 2 opened new positions in CRVO, 1 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Woodline Partners | 688,987 | $2M | New position |
| Vanguard | 354,950 | $1M | Unchanged |
| Sabby Management | 248,880 | $772K | New position |
| Geode Capital Management | 66,923 | $208K | Reduced 10.01% |
| BlackRock | 53,845 | $167K | Added 4.23% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is CRVO?
CervoMed Inc. Common Stock (CRVO) is listed on Nasdaq, where it has traded since June 18, 1996.
Who are the largest institutional holders of CRVO?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of CRVO were Woodline Partners, Vanguard and Sabby Management.
How many institutions own CRVO?
34 institutions reported a position in CRVO for the quarter ended June 30, 2026, worth $5.4 million in total.
Did institutions buy or sell CRVO last quarter?
Of the 5 largest reported holders, 2 opened new positions in CRVO, 1 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for CRVO.
Every reported institutional holder, plus insider and congressional trades in CRVO, on SentiSense.